Primary record
(5Z)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid
- 库存
- 8,945 克
- 纯度
- 99.7 %
- CAS
- 35121-78-9
化合物标识与属性
- CAS
- 35121-78-9
- PubChem CID
- 5280427
- SMILES
- CCCCC[C@@H](/C=C/[C@H]1[C@@H](C[C@H]2[C@@H]1CC(=CCCCC(=O)O)O2)O)O
- Canonical SMILES
- CCCCC[C@H](O)/C=C/[C@@H]1[C@H]2CC(=CCCCC(=O)O)O[C@H]2C[C@H]1O
名称与同义词
- epoprostenol
- prostacyclin
- prostaglandin I2
- Vasocyclin
- Flolan
- Prostaglandin X
- Epoprostenolum
- Prostacycline
- Veletri
- Cyclo-Prostin
- PGI2
- Epoprostenol sodium
- Epoprosterol sodium
- Sodium prostacyclin
- Epoprostenol (TN)
- AC1NQX0K
- PGI(sub 2)
- Epoprostenol (USAN/INN)
- Epoprostenol [USAN:INN]
- Epoprostenol (Prostacyclin)
- Epoprostenolum [INN-Latin]
- Try-200
- UNII-4K04IQ1OF4
- UNII-DCR9Z582X0
- C20H31NaO5
- C20H32O5.Na
- KB-IV-24
- 2,1,3-benzothiadiazol-5-amine
- Epoprostenol sodium [USAN:BAN]
- C20-H31-Na-O5
- TRY 200
- ACT-385781A
- EINECS 263-273-7
- C20-H32-O5
- CID5280427
- BRN 1690090
- PD009944
- U 53,217A
- C01312
- D00106
- 35121-78-9
- U 53217
- U 53,217
- (5Z)-9-deoxy-6,9-alpha-epoxy-delta-5-PGF1-alpha
- (5Z,13E)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate
- 5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid
- (5Z,13E)-(15S)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dienoate
- (5Z,13E,15S)-6,9a-epoxy-11a,15-dihydroxyprosta-5,13-dienoate
- (5Z,13E)-(15S)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dienoic acid
- (5Z,13E,15S)-6,9a-epoxy-11a,15-dihydroxyprosta-5,13-dienoic acid
- PGX
- (5z,13e)-(15s)-6,9-alpha-epoxy-11-alpha,15-dihydroxyprosta-5,13-dienoate
- (5Z,13E)-(15S)-6,9-alpha-epoxy-11-alpha,15-dihydroxyprosta-5,13-dienoic acid
- (5Z,13E)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoic acid
- (5Z,9-alpha,11-alpha,13E,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid
- (5Z,9a,11a,13E,15S)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dien-1-oate
- (5Z,9a,11a,13E,15S)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid
- (5Z,9alpha,11alpha,13E,15S)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dien-1-oate
- (5Z,9alpha,11alpha,13E,15S)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid
- 6,9-alpha-Epoxy-11-alpha,15(S)-dihydroxyprosta-5(Z),13(E)-dien-1-oic acid
- Sodium (5Z,13E,15S)-6,9alpha-epoxy-11alpha,15-dihydroxyprosta-5,13-dien-1-oate
- (5Z)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid
- (Z)-(3aR,4R,5R,6aS)-Hexahydro-5-hydroxy-4-((E)-(3S)-3-hydroxy-1-octenyl)-2H-cyclopenta(b)furan-delta(sup 2,delta)-valeric acid
- 136626-78-3
- 5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid
- 61849-14-7
- Sodium (Z)-(3aR,4R,5R,6aS)-hexahydro-5-hydroxy-4-((E)-(3S)-3-hydroxy-1-octenyl)-2H-cyclopenta(b)furan-delta(sup 2,delta)-valerate